SEC Form 4 · accession 0001162194-17-000031
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carlos V Paya
Director
Period of report
Mar 23, 2017
Accepted (ET)
Mar 27, 2017 · 1:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 23, 2017 | A | 10,000 | A | — | — | Common Stock | 10,000 | 10,000 | D |
| Employee Stock Option (Right to Buy)F3 | $5.52 | Mar 23, 2017 | A | 15,000 | A | — | Mar 23, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F225% of the shares underlying the Restricted Stock Units will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director.
- F325% of the shares subject to the Option will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director.